Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) closed at $8.84 in the last session, down -0.56% from day before closing price of $8.89. In other words, the price has decreased by -$0.56 from its previous closing price. On the day, 1.0 million shares were traded. AVAH stock price reached its highest trading level at $8.99 during the session, while it also had its lowest trading level at $8.705.
Ratios:
We take a closer look at AVAH’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.66 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.07. For the most recent quarter (mrq), Quick Ratio is recorded 1.23 and its Current Ratio is at 1.23. In the meantime, Its Debt-to-Equity ratio is 164.49 whereas as Long-Term Debt/Eq ratio is at 143.34.
On November 13, 2025, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $11.
JP Morgan Upgraded its Underweight to Neutral on September 18, 2025, while the target price for the stock was maintained at $10.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 24 ’25 when VIGANO PAUL R sold 1,500,000 shares for $9.00 per share. The transaction valued at 13,500,000 led to the insider holds 362,746 shares of the business.
J.H. Whitney Equity Partners V sold 1,251,909 shares of AVAH for $11,267,181 on Oct 24 ’25. The 10% Owner now owns 19,292,787 shares after completing the transaction at $9.00 per share. On Oct 24 ’25, another insider, WILLIAMS ROBERT M JR, who serves as the 10% Owner of the company, sold 1,500,000 shares for $9.00 each. As a result, the insider received 13,500,000 and left with 362,746 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVAH now has a Market Capitalization of 1846776576 and an Enterprise Value of 3204367616. As of this moment, Aveanna’s Price-to-Earnings (P/E) ratio for their current fiscal year is 24.56, and their Forward P/E ratio for the next fiscal year is 14.32. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.11. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.81 while its Price-to-Book (P/B) ratio in mrq is 201.09. Its current Enterprise Value per Revenue stands at 1.399 whereas that against EBITDA is 12.028.
Stock Price History:
The Beta on a monthly basis for AVAH is 2.05, which has changed by 0.9977528 over the last 52 weeks, in comparison to a change of 0.16081822 over the same period for the S&P500. Over the past 52 weeks, AVAH has reached a high of $10.32, while it has fallen to a 52-week low of $3.67. The 50-Day Moving Average of the stock is -3.13%, while the 200-Day Moving Average is calculated to be 35.15%.
Shares Statistics:
According to the various share statistics, AVAH traded on average about 1.39M shares per day over the past 3-months and 1004880 shares per day over the past 10 days. A total of 208.91M shares are outstanding, with a floating share count of 68.97M. Insiders hold about 66.99% of the company’s shares, while institutions hold 25.71% stake in the company. Shares short for AVAH as of 1764288000 were 3488981 with a Short Ratio of 2.51, compared to 1761868800 on 4265903. Therefore, it implies a Short% of Shares Outstanding of 3488981 and a Short% of Float of 5.09.
Earnings Estimates
. The current market rating for Aveanna Healthcare Holdings Inc (AVAH) reflects the collective analysis of 10.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.13, with high estimates of $0.15 and low estimates of $0.1.
Analysts are recommending an EPS of between $0.59 and $0.52 for the fiscal current year, implying an average EPS of $0.56. EPS for the following year is $0.59, with 11.0 analysts recommending between $0.72 and $0.37.
Revenue Estimates
According to 10 analysts,. The current quarter’s revenue is expected to be $621.53M. It ranges from a high estimate of $644.35M to a low estimate of $609M. As of. The current estimate, Aveanna Healthcare Holdings Inc’s year-ago sales were $519.87MFor the next quarter, 10 analysts are estimating revenue of $619.51M. There is a high estimate of $635.8M for the next quarter, whereas the lowest estimate is $589.9M.
A total of 10 analysts have provided revenue estimates for AVAH’s current fiscal year. The highest revenue estimate was $2.42B, while the lowest revenue estimate was $2.38B, resulting in an average revenue estimate of $2.39B. In the same quarter a year ago, actual revenue was $2.02BBased on 10 analysts’ estimates, the company’s revenue will be $2.57B in the next fiscal year. The high estimate is $2.59B and the low estimate is $2.52B.
